好消息!浙江将渐冻症等罕见病纳入医疗保障

2015-12-25 新华网 新华网

为了帮助群众化解巨额灾难性医疗费用支出风险,浙江省结合医保基金结余和罕见病发病诊治等情况,决定将部分罕见病纳入医疗保障范畴,进一步遏制因病致贫、因病返贫。浙江省人力社保厅、省民政厅、省财政厅、省卫生计生委联合发出的《关于加强罕见病医疗保障工作的通知》指出,自2016年1月1日起戈谢病、渐冻症、苯丙酮尿症列入罕见病医疗保障病种范围。据了解,保障对象包括现参加省基本医保并获得浙江户籍满5年的患者;或参

为了帮助群众化解巨额灾难性医疗费用支出风险,浙江省结合医保基金结余和罕见病发病诊治等情况,决定将部分罕见病纳入医疗保障范畴,进一步遏制因病致贫、因病返贫。

浙江省人力社保厅、省民政厅、省财政厅、省卫生计生委联合发出的《关于加强罕见病医疗保障工作的通知》指出,自2016年1月1日起戈谢病、渐冻症、苯丙酮尿症列入罕见病医疗保障病种范围。

据了解,保障对象包括现参加省基本医保并获得浙江户籍满5年的患者;或参加省基本医保,年龄不满5周岁,其父母一方获得浙江户籍满5年的浙江户籍患者。

浙江省人力社保厅相关负责人表示,纳入保障范围的罕见病患者,将由基本医保、大病保险、医疗救助、财政专项资金等逐层分担化解其合规医疗费用。

浙江大学的专家研究结果显示,一些罕见病的年人均治疗费用在数万元,还有很多的罕见病每年花费要数十万元,甚至数百万元。

原文件如下:

浙江省人力资源和社会保障厅 浙江省民政厅浙江省财政厅浙江省卫生和计划生育委员会关于加强罕见病医疗保障工作的通知

ZJSP13-2015-0031

浙人社发〔2015〕126号

各市、县(市、区)人力社保局、民政局、财政局、卫生计生委(局),嘉兴市社会保障事务局:

为贯彻落实国务院办公厅《转发民政部等部门关于进一步完善医疗救助制度全面开展重特大疾病医疗救助工作意见的通知》(国办发〔2015〕30号)和省政府办公厅《关于加快建立和完善大病保险有关问题的通知》(浙政办发〔2014〕122号)、《关于进一步完善医疗救助制度有关问题的通知》(浙政办发〔2014〕121号)要求,完善大病保险和医疗救助制度,建立健全多层次的医疗保障体系,帮助人民群众化解巨额灾难性医疗费用支出风险,有效解决因病致贫、因病返贫问题,经省政府同意,现将加强罕见病医疗保障工作的有关问题通知如下:

一、保障范围

根据我省经济社会发展水平、医保基金结余和罕见病发病诊治等情况,经组织专家论证,我省罕见病医疗保障病种范围暂定为戈谢病、渐冻症、苯丙酮尿症。

保障对象:现参加浙江省基本医疗保险,并获得浙江省户籍满5年的患者;或参加浙江省基本医疗保险,年龄不满5周岁,其父母一方获得浙江省户籍满5年的浙江省户籍患者。

二、保障方式

纳入保障范围的罕见病患者,由基本医保、大病保险、医疗救助逐层分担化解其合规医疗费用。合规医疗费用包括基本医疗保险政策范围内维持诊疗必须的医疗费用、罕见病特殊药品费用。

(一)基本医保。罕见病患者都应参加基本医疗保险。经济困难者,应通过医疗救助途径帮助其参加基本医疗保险。按基本医疗保险政策,报销基本医疗保险政策范围内的医疗费用。

(二)大病保险。通过谈判,将纳入保障范围的罕见病特殊药品列入浙江省大病保险用药报销范围,并按浙江省大病保险政策报销相关医疗费用。

(三)医疗救助。罕见病患者在报销基本医疗保险和大病保险后的剩余合规医疗费用,符合医疗救助条件的,予以医疗救助和专项救助。

三、服务管理

(一)疾病诊断。符合浙江省罕见病保障对象要求的患者须到浙江大学医学院附属第一医院、浙江大学医学院附属第二医院、浙江大学医学院附属邵逸夫医院、浙江大学医学院附属儿童医院、温州医科大学附属第二医院、省人民医院进行诊断。属于保障范围病种的,由医院出具《诊断证明》,患者凭医院出具的诊断证明回户籍所在地民政部门登记备案。罕见病患者每年须在12月31日前复检一次,凭医院出具的《诊断证明》回户籍所在地民政部门登记备案。

(二)费用保障。患者先按各地基本医疗保险、大病保险、医疗救助政策规定比例报销罕见病合规医疗费用,剩余罕见病合规医疗费用由财政安排资金,通过专项救助渠道解决。专项救助资金由省财政通过民政救助渠道予以补助。

四、部门职责

各级人力社保、民政、财政、卫生计生部门要高度重视罕见病的保障工作,建立部门协调机制,要根据各自职能做好相关工作。人力社保部门会同卫生计生部门确定罕见病保障病种及特殊用药范围,并将其纳入大病保险支付范围,做好患者基本医疗保险和大病保险段的医疗费用的报销工作。民政部门要加强罕见病保障对象的资格审查、档案管理、救助资金报销等工作。卫生计生部门要及时指定定点诊治医院,指导医疗机构做好诊断、治疗和信息管理等工作。财政部门要做好罕见病救助资金的筹集、拨付和管理工作。根据罕见病医疗保障制度实施情况,适时调整完善相关政策。

本通知自2016年1月1日起实施。

浙江省人力资源和社会保障厅   浙 江 省 民 政 厅

 浙 江 省 财 政 厅  浙江省卫生和计划生育委员会

2015年10月30日

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=49866, encodeId=90914986666, content=好消息啊 !哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Mon Dec 28 09:23:00 CST 2015, time=2015-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269689, encodeId=07b71269689bf, content=<a href='/topic/show?id=5e106628237' target=_blank style='color:#2F92EE;'>#渐冻症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66282, encryptionId=5e106628237, topicName=渐冻症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457223, encodeId=1172145e22313, content=<a href='/topic/show?id=075d3481802' target=_blank style='color:#2F92EE;'>#医疗保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34818, encryptionId=075d3481802, topicName=医疗保障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c0a5863810, createdName=linagood, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467112, encodeId=cbb0146e11211, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47806, encodeId=3cb34e8064a, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 25 22:34:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47787, encodeId=c6754e78774, content=支持。社会的进步,有望全国推广。, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Dec 25 22:06:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47691, encodeId=b06b4e69116, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 14:47:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47683, encodeId=d2324e68344, content=顶浙江卫计委!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Fri Dec 25 13:37:00 CST 2015, time=2015-12-25, status=1, ipAttribution=)]
    2015-12-28 xi.xiong

    好消息啊 !哈哈

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=49866, encodeId=90914986666, content=好消息啊 !哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Mon Dec 28 09:23:00 CST 2015, time=2015-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269689, encodeId=07b71269689bf, content=<a href='/topic/show?id=5e106628237' target=_blank style='color:#2F92EE;'>#渐冻症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66282, encryptionId=5e106628237, topicName=渐冻症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457223, encodeId=1172145e22313, content=<a href='/topic/show?id=075d3481802' target=_blank style='color:#2F92EE;'>#医疗保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34818, encryptionId=075d3481802, topicName=医疗保障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c0a5863810, createdName=linagood, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467112, encodeId=cbb0146e11211, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47806, encodeId=3cb34e8064a, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 25 22:34:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47787, encodeId=c6754e78774, content=支持。社会的进步,有望全国推广。, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Dec 25 22:06:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47691, encodeId=b06b4e69116, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 14:47:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47683, encodeId=d2324e68344, content=顶浙江卫计委!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Fri Dec 25 13:37:00 CST 2015, time=2015-12-25, status=1, ipAttribution=)]
    2015-12-27 xjy02
  3. [GetPortalCommentsPageByObjectIdResponse(id=49866, encodeId=90914986666, content=好消息啊 !哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Mon Dec 28 09:23:00 CST 2015, time=2015-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269689, encodeId=07b71269689bf, content=<a href='/topic/show?id=5e106628237' target=_blank style='color:#2F92EE;'>#渐冻症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66282, encryptionId=5e106628237, topicName=渐冻症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457223, encodeId=1172145e22313, content=<a href='/topic/show?id=075d3481802' target=_blank style='color:#2F92EE;'>#医疗保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34818, encryptionId=075d3481802, topicName=医疗保障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c0a5863810, createdName=linagood, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467112, encodeId=cbb0146e11211, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47806, encodeId=3cb34e8064a, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 25 22:34:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47787, encodeId=c6754e78774, content=支持。社会的进步,有望全国推广。, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Dec 25 22:06:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47691, encodeId=b06b4e69116, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 14:47:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47683, encodeId=d2324e68344, content=顶浙江卫计委!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Fri Dec 25 13:37:00 CST 2015, time=2015-12-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=49866, encodeId=90914986666, content=好消息啊 !哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Mon Dec 28 09:23:00 CST 2015, time=2015-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269689, encodeId=07b71269689bf, content=<a href='/topic/show?id=5e106628237' target=_blank style='color:#2F92EE;'>#渐冻症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66282, encryptionId=5e106628237, topicName=渐冻症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457223, encodeId=1172145e22313, content=<a href='/topic/show?id=075d3481802' target=_blank style='color:#2F92EE;'>#医疗保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34818, encryptionId=075d3481802, topicName=医疗保障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c0a5863810, createdName=linagood, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467112, encodeId=cbb0146e11211, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47806, encodeId=3cb34e8064a, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 25 22:34:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47787, encodeId=c6754e78774, content=支持。社会的进步,有望全国推广。, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Dec 25 22:06:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47691, encodeId=b06b4e69116, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 14:47:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47683, encodeId=d2324e68344, content=顶浙江卫计委!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Fri Dec 25 13:37:00 CST 2015, time=2015-12-25, status=1, ipAttribution=)]
    2015-12-27 syscxl
  5. [GetPortalCommentsPageByObjectIdResponse(id=49866, encodeId=90914986666, content=好消息啊 !哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Mon Dec 28 09:23:00 CST 2015, time=2015-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269689, encodeId=07b71269689bf, content=<a href='/topic/show?id=5e106628237' target=_blank style='color:#2F92EE;'>#渐冻症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66282, encryptionId=5e106628237, topicName=渐冻症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457223, encodeId=1172145e22313, content=<a href='/topic/show?id=075d3481802' target=_blank style='color:#2F92EE;'>#医疗保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34818, encryptionId=075d3481802, topicName=医疗保障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c0a5863810, createdName=linagood, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467112, encodeId=cbb0146e11211, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47806, encodeId=3cb34e8064a, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 25 22:34:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47787, encodeId=c6754e78774, content=支持。社会的进步,有望全国推广。, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Dec 25 22:06:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47691, encodeId=b06b4e69116, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 14:47:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47683, encodeId=d2324e68344, content=顶浙江卫计委!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Fri Dec 25 13:37:00 CST 2015, time=2015-12-25, status=1, ipAttribution=)]
    2015-12-25 老段

    好消息

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=49866, encodeId=90914986666, content=好消息啊 !哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Mon Dec 28 09:23:00 CST 2015, time=2015-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269689, encodeId=07b71269689bf, content=<a href='/topic/show?id=5e106628237' target=_blank style='color:#2F92EE;'>#渐冻症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66282, encryptionId=5e106628237, topicName=渐冻症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457223, encodeId=1172145e22313, content=<a href='/topic/show?id=075d3481802' target=_blank style='color:#2F92EE;'>#医疗保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34818, encryptionId=075d3481802, topicName=医疗保障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c0a5863810, createdName=linagood, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467112, encodeId=cbb0146e11211, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47806, encodeId=3cb34e8064a, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 25 22:34:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47787, encodeId=c6754e78774, content=支持。社会的进步,有望全国推广。, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Dec 25 22:06:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47691, encodeId=b06b4e69116, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 14:47:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47683, encodeId=d2324e68344, content=顶浙江卫计委!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Fri Dec 25 13:37:00 CST 2015, time=2015-12-25, status=1, ipAttribution=)]
    2015-12-25 dhzzm

    支持。社会的进步,有望全国推广。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=49866, encodeId=90914986666, content=好消息啊 !哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Mon Dec 28 09:23:00 CST 2015, time=2015-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269689, encodeId=07b71269689bf, content=<a href='/topic/show?id=5e106628237' target=_blank style='color:#2F92EE;'>#渐冻症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66282, encryptionId=5e106628237, topicName=渐冻症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457223, encodeId=1172145e22313, content=<a href='/topic/show?id=075d3481802' target=_blank style='color:#2F92EE;'>#医疗保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34818, encryptionId=075d3481802, topicName=医疗保障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c0a5863810, createdName=linagood, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467112, encodeId=cbb0146e11211, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47806, encodeId=3cb34e8064a, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 25 22:34:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47787, encodeId=c6754e78774, content=支持。社会的进步,有望全国推广。, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Dec 25 22:06:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47691, encodeId=b06b4e69116, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 14:47:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47683, encodeId=d2324e68344, content=顶浙江卫计委!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Fri Dec 25 13:37:00 CST 2015, time=2015-12-25, status=1, ipAttribution=)]
    2015-12-25 忠诚向上

    支持

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=49866, encodeId=90914986666, content=好消息啊 !哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Mon Dec 28 09:23:00 CST 2015, time=2015-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269689, encodeId=07b71269689bf, content=<a href='/topic/show?id=5e106628237' target=_blank style='color:#2F92EE;'>#渐冻症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66282, encryptionId=5e106628237, topicName=渐冻症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457223, encodeId=1172145e22313, content=<a href='/topic/show?id=075d3481802' target=_blank style='color:#2F92EE;'>#医疗保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34818, encryptionId=075d3481802, topicName=医疗保障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c0a5863810, createdName=linagood, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467112, encodeId=cbb0146e11211, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Sun Dec 27 01:48:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47806, encodeId=3cb34e8064a, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 25 22:34:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47787, encodeId=c6754e78774, content=支持。社会的进步,有望全国推广。, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Dec 25 22:06:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47691, encodeId=b06b4e69116, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 14:47:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47683, encodeId=d2324e68344, content=顶浙江卫计委!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Fri Dec 25 13:37:00 CST 2015, time=2015-12-25, status=1, ipAttribution=)]
    2015-12-25 vpssa

    顶浙江卫计委!

    0

相关资讯

Nature:英国万人基因组计划揭示罕见突变与人类疾病关系

近日,著名国际学术期刊Nature刊登了迄今为止最大的人群基因组测序研究,而关于这些数据的来源和用途也同一时间发表在了Nature, Nature Genetics, Bioinformatics以及Nature Communication等Nature系列杂志上。罕见基因突变是DNA中携带的遗传变化,而在一个人群中携带这种突变的人相对较少。英国的万人研究就是为了探究罕见遗传突变与人类疾病和疾病风

罕见病:改变从了解开始

编者按:有多少人还记得去年夏天狂欢风靡的冰桶挑战,又有多少人还记得这些需要帮助的罕见病患者。正如罕见病发展中心主任黄如方所言,我们做的还远远不够。生物谷也尽一己之力,呼吁发起更多的学者关注罕见病,借助2015中国人类罕见病的基础和转化医学高峰论坛推动罕见病研究,提高诊治水平,并希望以此为契机,促进社会对罕见病患者的关爱,推动相关法律政策的制定原标题 《新年寄语:新的一年,不说快乐说加油》当中国

罕见病救助:“青岛模式”带给我们的思考与启示

引言:去年盛夏,"冰桶挑战"的火热,让"罕见病"这个在国内还不被大众所了解的领域,在近一年时间内频频进入公众视野。据国内医学界估算,在我国有超过1600多万的各类罕见病患者,这是一个不可忽视的庞大社会群体。随着国内经济、文化的快速发展,居民对生活质量的追求,对健康的期望,对享有医疗保障的需要,已越来越高。罕见病领域所面临的问题,已成了国家精神文明建设,创建社会和谐家园,实现伟大"中国梦"征途上

不孤独的孤儿药(下篇):孤独在中国

和欧美孤儿药研发火爆现状截然不同,目前我国的孤儿药研发和欧美相比实在是冰火两重天,中国本土自主研发成功的孤儿药微乎其微,深圳微芯的西达苯胺算是一个罕见的亮点,今年年初获批上市的首个适应症是复发及难治性外周T细胞淋巴瘤,是中国首个授权美国等发达国家专利使用的原创新药。由于像西达苯胺这样用于治疗罕见病的中国本土孤儿药比罕见病本身要罕见的多,所以中国患者和家属只能期待国外药品公司在中国尽快获得罕

JAMA:罕见病诊断的新思路

罕见病的诊断和治疗一直都是难题,而测序技术的出现则带来了一丝曙光。一般来说,患者出现一些症状后,通常先看医生,然后开展外显子组测序,并借助研究人员,找到分子机制。然而,根据《美国医学会杂志》(JAMA)上的一篇文章,这个顺序现在反过来了。文章讲述了一个荷兰男孩的故事。他叫Vincent Pieterse,出生在2002年底。在婴儿时期,他似乎很健康,不过随着他渐渐长大,出现了学习障碍、轻微自闭症、

我国罕见病治疗诊断现状

不久前风靡一时的"挑战冰桶",让社会大众开始逐渐关注到了渐冻人、瓷娃娃等罕见病群体。罕见病是指那些患病率较低的疾病,又称"孤儿病"。 根据世界卫生组织(WHO)的定义,罕见病为患病人数占总人口的0.65‰~1‰的疾病。世界各国根据自己国家的具体情况,对罕见病的认定标准存在一定的差异。例如,美国将罕见病定义为每年患病人数少于20万人(或发病人口比例小于1/1500)的疾病;日本规定,罕见病为患病